Company Filing History:
2 out of 134 
2 out of 3,687 
2 out of 8 Years Active: 2024
Title: **The Impactful Innovations of Fidel P Zavala**
Introduction
Fidel P Zavala, a notable inventor based in Baltimore, MD, has made significant strides in the field of immunology with his innovative contributions. With a total of two patents to his name, Zavala focuses on the treatment of malaria, a disease that continues to affect millions worldwide.
Latest Patents
Zavala's recent patents revolve around the development of malaria immunogens. His first patent describes an immunogen comprising an immunogenic carrier linked to an antigenic malaria circumsporozoite protein (CSP) peptide. This particular peptide includes the sequence NPDPNANPNVDPNAN (amino acids 5-19 of SEQ ID NO:1), which is designed to be administered to individuals at risk of malaria.
In his second patent, Zavala presents another immunogen that utilizes a slightly different peptide sequence, NANPNVDPNANPNVD (SEQ ID NO:2). This innovation allows for the immunogen to be administered not only to subjects at risk of malaria but also to those experiencing blood stage parasitemia, potentially in combination with other therapeutic agents for enhanced efficacy.
Career Highlights
Throughout his career, Zavala has collaborated with prestigious institutions, including Unm Rainforest Innovations and The Johns Hopkins University. His focus on malaria treatment exemplifies his commitment to advancing medical science and improving public health outcomes.
Collaborations
Fidel P Zavala has worked alongside prominent scientists such as Bryce Chackerian and David S Peabody. These collaborations have undoubtedly enriched his research and contributed to his innovative success in developing effective malaria treatments.
Conclusion
Fidel P Zavala stands out as an influential figure in the fight against malaria, bringing forth innovative solutions through his patents. His work not only showcases his ingenuity as an inventor but also highlights the importance of collaboration in advancing healthcare research. The contributions of Zavala and his peers are vital in the ongoing quest to combat one of the world's most persistent diseases.